So where does the Anteobind come from for the US tests that have been produced - how do we know that AOD don't already have supply agreement with Ellume US? I would guess they do on the same rates as the Australian agreement - hard to argue otherwise. Or the US Ellume bought the Anteobind from the Australian branch, or the Australian branch just gave out to the US branch - gee who knows???
Ellume was never a competitor in the Aussie market for RATs - just the myriad of RATs from China, Abbot, Panbio etc etc etc. I don't see us gaining any inherent advantage from Ellume closing its doors (if it in fact does)
For a post with 39 likes and 15 great analysis it doesn't really stack up too me....Sorry...
Happy for alternative proofs
ADO Price at posting:
5.8¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)